MedTrace Logo

Lung Cancer Registry for Lung Cancer Patients

NCT03276429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2019-03-14

No results posted yet for this study

Summary

In the light of a new era in the management of lung cancer this non-interventional study intend to capture all the epidemiological, clinical, pathological, molecular and treatment parameters of non-small cell (NSCLC) and small cell (SCLC) lung cancer patients from a tertiary Oncology Clinic in an Electronic Data Base (EDB).

Conditions

Sponsors & Collaborators

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • Oncology Center of Biochemical Education And Research

    lead OTHER

Principal Investigators

  • Konstantinos N Syrigos, MD,PhD · Non-Governmental, Non-Profit Organization

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-08
Primary Completion
2018-12-27
Completion
2018-12-27

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276429 on ClinicalTrials.gov